179 related articles for article (PubMed ID: 8279009)
1. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients.
Sokal EM; Caragiozoglou T; Lamy M; Reding R; Otte JB
Transplantation; 1993 Dec; 56(6):1394-8. PubMed ID: 8279009
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
3. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infections in children after transplantation of the small intestine.
Finn L; Reyes J; Bueno J; Yunis E
Am J Surg Pathol; 1998 Mar; 22(3):299-309. PubMed ID: 9500771
[TBL] [Abstract][Full Text] [Related]
5. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
[TBL] [Abstract][Full Text] [Related]
8. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience.
Rogers BB; Sommerauer J; Quan A; Timmons CF; Dawson DB; Scheuermann RH; Krisher K; Atkins C
Pediatr Dev Pathol; 1998; 1(6):480-6. PubMed ID: 9724334
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients.
Rogers BB; Conlin C; Timmons CF; Dawson DB; Krisher K; Andrews WS
Pediatr Pathol Lab Med; 1997; 17(3):391-400. PubMed ID: 9185219
[TBL] [Abstract][Full Text] [Related]
11. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
[TBL] [Abstract][Full Text] [Related]
13. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
[No Abstract] [Full Text] [Related]
14. Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.
Serinet MO; Jacquemin E; Habes D; Debray D; Fabre M; Bernard O
J Pediatr Gastroenterol Nutr; 2002 Apr; 34(4):389-93. PubMed ID: 11930095
[TBL] [Abstract][Full Text] [Related]
15. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
[TBL] [Abstract][Full Text] [Related]
16. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
19. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients.
Renard TH; Andrews WS; Foster ME
Transplant Proc; 1991 Feb; 23(1 Pt 2):1473-6. PubMed ID: 1846468
[No Abstract] [Full Text] [Related]
20. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
